← International Flavors & Fragrances overview

International Flavors & Fragrances vs Wanhua Chemical: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

International Flavors & Fragrances Inc (IFF)

Q3 2026
▲3▼1

IFF's big portfolio overhaul and buyback drive the story

  • IFF sells Food Ingredients for $3.8B and launches $2.5B buyback IFF agreed to sell its Food Ingredients unit to CVC for about $3.8 billion and announced a $2.5 billion share buyback, including a $500 million accelerated repurchase. This shrinks the company but sharpens focus on higher-margin Taste, Scent, and Health & Biosciences, and returning cash supports the stock.

    This is the biggest strategic event of the period, reshaping IFF's business and capital returns.

  • Q2 results miss and guidance cut on stranded costs IFF's Q2 revenue fell 29% to $1.95 billion and missed estimates badly, while full-year guidance was cut to $7.5 billion. Management blamed temporary stranded costs from the divestiture, but the miss and lower outlook weigh on investor confidence.

    The earnings miss and guidance cut are the main negative counterweight to the positive portfolio moves.

  • New product launches in scent and animal nutrition IFF launched SENSORA pro-fragrance technology, Omni-Bos PHY enzyme for dairy cattle, and AQUASCENT water-based fragrance carrier. These innovations target higher-margin growth areas and support the company's focus on R&D-led differentiation.

    Product launches show IFF's innovation pipeline and support future revenue growth.

  • Analysts and value funds see IFF as undervalued Morgan Stanley and Argus raised price targets, and Heartland Mid Cap Value Fund called IFF a deep-value opportunity trading at a discount to Givaudan. The new buyback and portfolio streamlining are seen as catalysts to close the valuation gap.

    This reflects external validation of IFF's turnaround story and potential upside.

August 2026
▲3▼1

IFF's big portfolio overhaul and buyback drive the story

  • IFF sells Food Ingredients for $3.8B and launches $2.5B buyback IFF agreed to sell its Food Ingredients unit to CVC for about $3.8 billion and announced a $2.5 billion share buyback, including a $500 million accelerated repurchase. This shrinks the company but sharpens focus on higher-margin Taste, Scent, and Health & Biosciences, and returning cash supports the stock.

    This is the biggest strategic event of the period, reshaping IFF's business and capital returns.

  • Q2 results miss and guidance cut on stranded costs IFF's Q2 revenue fell 29% to $1.95 billion and missed estimates badly, while full-year guidance was cut to $7.5 billion. Management blamed temporary stranded costs from the divestiture, but the miss and lower outlook weigh on investor confidence.

    The earnings miss and guidance cut are the main negative counterweight to the positive portfolio moves.

  • New product launches in scent and animal nutrition IFF launched SENSORA pro-fragrance technology, Omni-Bos PHY enzyme for dairy cattle, and AQUASCENT water-based fragrance carrier. These innovations target higher-margin growth areas and support the company's focus on R&D-led differentiation.

    Product launches show IFF's innovation pipeline and support future revenue growth.

  • Analysts and value funds see IFF as undervalued Morgan Stanley and Argus raised price targets, and Heartland Mid Cap Value Fund called IFF a deep-value opportunity trading at a discount to Givaudan. The new buyback and portfolio streamlining are seen as catalysts to close the valuation gap.

    This reflects external validation of IFF's turnaround story and potential upside.

Latest
▲3▼1

IFF's big portfolio overhaul and buyback drive the story

  • IFF sells Food Ingredients for $3.8B and launches $2.5B buyback IFF agreed to sell its Food Ingredients unit to CVC for about $3.8 billion and announced a $2.5 billion share buyback, including a $500 million accelerated repurchase. This shrinks the company but sharpens focus on higher-margin Taste, Scent, and Health & Biosciences, and returning cash supports the stock.

    This is the biggest strategic event of the period, reshaping IFF's business and capital returns.

  • Q2 results miss and guidance cut on stranded costs IFF's Q2 revenue fell 29% to $1.95 billion and missed estimates badly, while full-year guidance was cut to $7.5 billion. Management blamed temporary stranded costs from the divestiture, but the miss and lower outlook weigh on investor confidence.

    The earnings miss and guidance cut are the main negative counterweight to the positive portfolio moves.

  • New product launches in scent and animal nutrition IFF launched SENSORA pro-fragrance technology, Omni-Bos PHY enzyme for dairy cattle, and AQUASCENT water-based fragrance carrier. These innovations target higher-margin growth areas and support the company's focus on R&D-led differentiation.

    Product launches show IFF's innovation pipeline and support future revenue growth.

  • Analysts and value funds see IFF as undervalued Morgan Stanley and Argus raised price targets, and Heartland Mid Cap Value Fund called IFF a deep-value opportunity trading at a discount to Givaudan. The new buyback and portfolio streamlining are seen as catalysts to close the valuation gap.

    This reflects external validation of IFF's turnaround story and potential upside.

Wanhua Chemical Group Co Ltd (600309.CG)

Q3 2026
▲3

Wanhua's profit surges on price hikes and tight MDI supply

  • Wanhua leads global MDI/TDI price hikes Wanhua and rivals Huntsman and BASF raised MDI and TDI prices by $200-300 per tonne, driven by higher costs and plant maintenance. As the world's largest MDI producer, Wanhua benefits directly from higher prices, lifting its revenue and profit.

    This is the core pricing driver behind Wanhua's earnings surge and stock appeal.

  • First-half profit jumps 64%, dividend announced Wanhua reported first-half revenue up 31% to 119.3 billion yuan and net profit up 64% to 10.06 billion yuan, with a 2.5 billion yuan dividend. Strong results confirm the upcycle and reward shareholders, supporting the stock price.

    Earnings and dividend are the clearest fundamental proof of the company's health.

  • Global MDI supply stays tight through 2028 Analysts expect a global MDI supply-demand gap of about 220,000 tonnes from 2026 to 2028, with capacity shifting to China where Wanhua has a cost advantage. Tight supply supports higher prices and margins for Wanhua.

    This structural supply gap underpins the positive long-term outlook for Wanhua's main product.

  • Maintenance shutdowns and restarts balance supply Wanhua's Yantai MDI plant shut for 45 days from August 10 and restarted by September 29, while its Fujian and Hungarian units also resumed. These routine outages temporarily tighten supply but restore volumes, keeping overall supply stable.

    Plant maintenance and restarts affect near-term supply but are routine and largely neutral for the big picture.

August 2026
▲3

Wanhua's profit surges on price hikes and tight MDI supply

  • Wanhua leads global MDI/TDI price hikes Wanhua and rivals Huntsman and BASF raised MDI and TDI prices by $200-300 per tonne, driven by higher costs and plant maintenance. As the world's largest MDI producer, Wanhua benefits directly from higher prices, lifting its revenue and profit.

    This is the core pricing driver behind Wanhua's earnings surge and stock appeal.

  • First-half profit jumps 64%, dividend announced Wanhua reported first-half revenue up 31% to 119.3 billion yuan and net profit up 64% to 10.06 billion yuan, with a 2.5 billion yuan dividend. Strong results confirm the upcycle and reward shareholders, supporting the stock price.

    Earnings and dividend are the clearest fundamental proof of the company's health.

  • Global MDI supply stays tight through 2028 Analysts expect a global MDI supply-demand gap of about 220,000 tonnes from 2026 to 2028, with capacity shifting to China where Wanhua has a cost advantage. Tight supply supports higher prices and margins for Wanhua.

    This structural supply gap underpins the positive long-term outlook for Wanhua's main product.

  • Maintenance shutdowns and restarts balance supply Wanhua's Yantai MDI plant shut for 45 days from August 10 and restarted by September 29, while its Fujian and Hungarian units also resumed. These routine outages temporarily tighten supply but restore volumes, keeping overall supply stable.

    Plant maintenance and restarts affect near-term supply but are routine and largely neutral for the big picture.

Latest
▲3

Wanhua's profit surges on price hikes and tight MDI supply

  • Wanhua leads global MDI/TDI price hikes Wanhua and rivals Huntsman and BASF raised MDI and TDI prices by $200-300 per tonne, driven by higher costs and plant maintenance. As the world's largest MDI producer, Wanhua benefits directly from higher prices, lifting its revenue and profit.

    This is the core pricing driver behind Wanhua's earnings surge and stock appeal.

  • First-half profit jumps 64%, dividend announced Wanhua reported first-half revenue up 31% to 119.3 billion yuan and net profit up 64% to 10.06 billion yuan, with a 2.5 billion yuan dividend. Strong results confirm the upcycle and reward shareholders, supporting the stock price.

    Earnings and dividend are the clearest fundamental proof of the company's health.

  • Global MDI supply stays tight through 2028 Analysts expect a global MDI supply-demand gap of about 220,000 tonnes from 2026 to 2028, with capacity shifting to China where Wanhua has a cost advantage. Tight supply supports higher prices and margins for Wanhua.

    This structural supply gap underpins the positive long-term outlook for Wanhua's main product.

  • Maintenance shutdowns and restarts balance supply Wanhua's Yantai MDI plant shut for 45 days from August 10 and restarted by September 29, while its Fujian and Hungarian units also resumed. These routine outages temporarily tighten supply but restore volumes, keeping overall supply stable.

    Plant maintenance and restarts affect near-term supply but are routine and largely neutral for the big picture.